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ABSTRACT 
 
 
BACKGROUND: The purpose of this study was to determine the volume of two 
complex paediatric procedures at the tertiary care centres in Ontario over the last 20 years 
in two disciplines, analyze outcomes and explore the possibility of an outcome volume 
relationship. 
METHODS: A population based cohort study of patients undergoing TEF repair and 
pyeloplasty at 4 paediatric centres in Ontario between 1993 and 2013 was carried out. 
Administrative data sets were linked using unique encoded identifiers and analyzed at the 
Institute for Clinical Evaluative Sciences (ICES). 
RESULTS: In TEF repair and pyeloplasty, there was significant difference in hospital 
volume between institutions and no significant difference in main outcome–reoperation 
rate between them.  
CONCLUSIONS: This study demonstrated that although the institutional volume and 
surgeon volume is different, the reoperation rate between institutions is similar in tertiary 
paediatric Ontario centres. 
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Paediatric Surgical Outcomes Across Ontario 
1.1. Background 
The outcome of surgical procedures are linked to a number of factors- these may 
include but are no exclusively limited to the clinical condition of the patient, the pre, post 
and inter-operative care, the complexity of the surgical procedure and the experience of 
the surgeon. Over the past few decades, many studies, across a variety of surgical 
procedures have shown that the outcomes of certain surgical procedures are related to the 
volume of operations performed at the centre.  Simply put, patients treated in hospitals 
performing fewer operations are more likely to have complications [1-5].  
The question remains as to why this is the case and a number of theories have 
been suggested. Hospitals performing more surgeries have not only more experienced 
surgeons, but also highly qualified, more experienced teams and broader range of 
resources [6]. There is also more likely to be a standardised care pathway in bigger 
centres, a concept known to be associated with better outcomes [7-9].  These higher 
volume hospitals then become known as “centres of excellence” and the referral pattern 
migrates towards these centres [10, 11]. 
 A systematic review and methodological critique of the relationship between 
surgical volume and outcome by Ethan et al looked at 135 studies over the last twenty 
years [1]. They showed that overall 71% of these studies revealed a positive association 
between outcomes, hospital volume and individual surgeon volume.  A positive 
relationship between hospital volume and outcome was reported in 44% of articles with 
no risk adjustment, this increased to 82% with risk adjustment based on administrative 
data and to 50% with risk adjustment based on clinical data. A positive association 
between physician volume and outcome was found in 62% studies with no risk 
adjustment, 68% with adjustment based on administrative data and to 73% using clinical 
risk-adjustment models. A larger systematic review from 2005 [12] showed that amongst 
313 studies, 68% found a positive relationship between hospital and physician volume 
and outcomes, but the remaining 32% showed no significant difference.  One percent of 
the studies (4 of 3143) showed a significant association between higher volumes and 
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poorer outcomes [11, 13, 14]. Wade et al., [13] demonstrated a better outcome following 
a Whipples procedure that were carried out at lower volume hospitals and a higher thirty-
day mortality rate in higher volume centers.  Similarly Luft et al., looked at 17 different 
surgically treated conditions in one million patients in over 900 hospitals. In two of his 
analysis the higher volume hospitals had higher mortality rates in patients with 
subarachnoid haemorrhage and patients with acute appendicitis. [11]. This finding of a 
few discrepant results may be explained on the basis of random error, since the 
probability that a typical analysis will produce a statistically significant result by chance 
alone (when truly is no difference) is approximately 5% [11]. 
The relationship between surgical volume and outcome has been mostly studied 
in patients undergoing complex abdominal, vascular and cardiac procedures in the United 
States [1, 12, 15, 16]. One of the first studies to be done in Canada was in 1995 on 
coronary artery bypass surgery, and it showed no volume-outcome effect [17]. Later 
Canadian studies showed positive relation between volume and outcomes with better 
results in centres with higher volume [18-21]. However at the same time many other 
Canadian studies on various procedures showed no relation between patient volume and 
outcomes [21-27]. 
 The majority of outcome studies have looked at procedures that are relatively high 
risk, such as cardiac surgeries and vascular surgeries, and in the elderly adult population. 
It is difficult to ensure that the comorbidities between the populations studied are the 
same and the complexity of the surgical procedure itself is truly identical [28]. Most of 
the studies are carried out in singles centres and it is very difficult to compare them as 
they are done at different times (years), by different kinds of teams (academic versus 
non-academic) and as mentioned earlier the complexity of each surgery may not be the 
same [29-32].  Furthermore many of the studies are heterogeneous reporting a 
combination of hospital volume [18, 21, 22, 33], and total surgeon volume or individual 
surgeon volume [3, 20, 27, 34]. 
 The influence of volume on outcomes in paediatric surgery procedures has been 
even less studied than in adult surgery. There is much less data, fewer patients, paediatric 
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specific centres and paediatric surgeons. In contrast the scope of paediatric surgery is 
large varying between procedures that are common and simple, such as inguinal hernia 
repair, to those that are rare and very complex associated with congenital defects. Up 
until the early 90’s paediatric surgery in Canada was distributed among both community 
and tertiary care hospitals.  There were many community physicians that performed a 
variety of both paediatric and adult procedures. Although the paediatric population has 
remained stable, the way in which paediatric surgical care is provided has changed. The 
infra-structure, the skills of the anaesthetist, the pre and post nursing care of the patients 
has become more complex. As a consequence most paediatric surgical procedures, 
certainly those in patients less than 1-2 years of age, or older with complex care needs are 
now performed in the 17 tertiary academic hospitals across Canada.  Despite this 
consolidation the number of complex procedures at each tertiary care centre can remain 
quite low and some paediatric services such as paediatric cardiac surgery only occur in 5 
centres in Canada. 
 Most of the paediatric volume outcome studies reported to date are from the US, 
are difficult to interpret and do not apply to the Canadian landscape. The studies combine 
data from paediatric procedures carried out in both adult and paediatric centres. For 
example a recent study by Salazar et al., [35] in the US looked at mortality following all 
surgical procedures carried out in 173 hospitals and in over 236,000 paediatric cases 
within 4 year time frame (2006-2010) and found a significant difference in mortality 
between lower and higher volume centres, in favour of the high-volume centres. 
However, authors noticed that 2/3 (67.7%) of outlier hospitals, were not specialized 
paediatric centres, which was certainly a confounder in the analysis of the data and 
confirms the need for comparison of similar paediatric institutions. A study by Chen et 
al., showed that both paediatric (PS) and adult general surgeons (GS), who performed 
greater than 37 paediatric cholecystectomies per year had better outcomes than those who 
performed fewer than 37 cholecystectomies per year (complication rate:13% vs. 15%, 
length of stay 2.3 vs. 2.6 days and lower costs: $7761 vs. $9462) [34]. There was no 
difference between paediatric and adult surgeons performing that procedure (GS vs. PS: 
complication rate: 14.9 vs. 15.6, LOS-2.5 vs. 2.5 days and costs-$9055 vs.$9484)[34]. 
However this is not a complex paediatric surgical procedure and is certainly not exclusive 
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to the domain of the specialty trained paediatric surgeon. Similar results have been 
obtained for the surgical procedures of pyloromyotomy and appendectomy [36-38]. Two 
Canadian studies have reported volume outcome results in studies that looked at the 
effect of subspecialty training on the outcomes following pyloromyotomy [38] and hernia 
repair [39]. Pyloromyotomy is a procedure that used to be performed routinely in 
community hospitals but over time has become consolidated, for the most part to the 
tertiary care centres in Canada. Langer et al., reported that 67.9% of patients were 
operated on by paediatric surgeons and 32% by general surgeons. The general surgeons 
had a complication rate 4 times that of the paediatric surgeon and sub analysis suggested 
that in both the general surgeon and the paediatric surgeon higher volumes resulted in 
better outcomes [38]. Similarly in the study by Bernstein et al., the rate of recurrent 
inguinal hernias was higher in the general surgeon group compared with the paediatric 
surgeon. There was an inverse correlation between surgeon volume and reoccurrence risk 
among the general surgeons [39]. Both the US and Canadian studies support the 
consolidation of paediatric care to paediatric specific centres.  
 Unlike the adult volume outcome literature and with the exception of the 
paediatric cardiac literature [16, 40] there is no data that compares the volume outcome 
relationship for the complex paediatric surgical procedures that are only carried out at 
specific paediatric centres. In Canada due to the small volume of paediatric cardiac 
procedures care is consolidated to only a few childrens hospitals.  As yet this 
consolidation has not been applied to other complex paediatric procedures e.g. trachea-
esophageal fistula repair. There are a number of issues associated with delivering 
paediatric surgical care in a limited number of locations. First one has to consider the 
demographics of the patient. Many patients would have to travel even further to receive 
care, the patient and primary care giver would be separated from the family unit for 
potentially a protracted length of time. Second the centralization of surgical care will 
impact other areas that provide support to the surgical patients, such as the paediatric 
critical care units and other specialized services. Furthermore the development of new or 
expansion of existing structures would be very costly.  
 It is important to evaluate the association of centre volume with the outcomes of 
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surgical procedures in children undergoing procedures at different centers in Canada. 
First it is necessary to determine if a relationship between volume and the outcome of a 
number of complex paediatric procedures does exist.  A clearer understanding of the 
relationship may have a significant impact on strategies for improving clinical care, such 
as consolidation of services to a few centres in Ontario or Canada or maybe a more 
consistent approach to pre- operative evaluation of the patient and post –operative care.  
 Ontario is the most populated province in Canada with a paediatric population of 
2.2 million with 142.000 births per year [41, 42]. It is acknowledged that most medical in 
hospital care of the children in Ontario is provided in the community hospitals but 
surgical care is, for the majority concentrated to the 5  Paediatric Academic Health 
Centres situated in Southern Ontario (Hospital for Sick Children in Toronto (HSC), 
Children’s Hospital of Eastern Ontario in Ottawa (CHEO), McMaster Children’s 
Hospital in Hamilton, Children’s Hospital at London Health Sciences Centre in London, 
and Kingston General Hospital (KGH) and Hotel Dieu Hospital (HDH) in Kingston). All 
of these have highly sub-speciality-trained paediatric surgeons including  paediatric 
surgeons (for the purpose of this study and according to the terminology of the Royal 
college of Physicians and Surgeons of Canada paediatric surgeon describes the paediatric 
general surgeon), paediatric urologists, neurosurgeons, ophthalmologists, orthopedic 
surgeons to name a few. All centres have experienced support staff and the infrastructure 
such as the paediatric critical care units, which are needed to provide the best care for the 
children of Ontario. There is also a current model of consolidation with paediatric 
surgical cardiac care regionalised to HSC and CHEO. Thus Ontario provides an excellent 
landscape to start to look at the volume outcome relationship in paediatric surgery in a 
meaningful manner.  
1.2. Purpose 
The purpose of this study was to determine the volume of the following three 
complex paediatric procedures at the tertiary care centres in Ontario over the last 20 years 
ii. Study the outcomes of the procedures ii. Explore the possibility of an outcome volume 
relationship both at the hospital volume level but also at the individual surgeon level. The 
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project will incorporate the use of the Institute for Clinical Evaluative Sciences (ICES) 
data sets, to identify the volume of a number of the predetermined complex surgical 
procedures Tracheoesophageal Fistula (TEF) repair and pyeloplasty and associated 
outcomes in the paediatric population.  
1.3. Hypothesis  
 We hypothesise that there is no difference in outcomes in complex paediatric 
surgery procedures performed by sub-specialty trained surgeons in children’s hospitals in 
Ontario, despite predicted differences in operative volume. 
1.4. Methods 
1.4.1. Study Design  
 A population based retrospective cohort study of all paediatric patients 
undergoing TEF repair and pyeloplasty at paediatric centres in Ontario (Hospital for Sick 
Children in Toronto Children’s Hospital of Eastern Ontario in Ottawa, McMaster 
Children’s Hospital in Hamilton, Children’s Hospital of Western Ontario in London) 
between April 1st 1993 and March 31st 2013 was carried out. Kingston General Hospital 
and Hotel Dieu Hospital Kingston were excluded because the provision of paediatric 
tertiary care surgical service was limited for the duration of the study period. The 
province of Ontario, Canada has universal access to hospital care and these encounters 
are recorded in large population-based health care databases dating back to 1992. 
Administrative datasets were linked using unique, encoded identifies and analyzed at the 
Institute for Clinical Evaluative Sciences (ICES).  
1.4.2. Procedures chosen 
 A retrospective cohort study of paediatric patients undergoing one of the 
following two surgical procedures was carried out. The procedures TEF repair and 
pyeloplasty were chosen based on the following criteria: 
a. Performed at all of the identified study sites.  
b. Considered a procedure that is complex (index procedure).  
7 
 
 
 
c. Performed only by a paediatric subspecialty trained surgeon.  
d. The surgical technique has not changed significantly over the study period. 
e. Is associated with post-operative complications that reflect the outcome of the 
procedure. 
f. The co-morbidities of the patient do not impact the outcome of the surgical 
procedure. 
g. The procedure and complications could be identified in the data sets used in the 
study.  
h. Unlike the adult literature where an assignment of patient complexity such as the 
Charleston score can be applied there is no such risk adjustment for complexity in 
the paediatric literature. It is very difficult to exclude completely the effect of 
individual patient comorbidities on parameters such as hospital length and morbidity. 
For this reason we excluded these measures from our analysis. 
1.4.3. Data Source 
 The province on Ontario, Canada has universal access to hospital care and these 
encounters are recorded in large population-based health care databases dating back to 
1992. Administrative datasets were linked using unique, encoded identifies and analyzed 
at the Institute for Clinical Evaluative Sciences (ICES) Western site, located in London, 
Ontario, Canada. The ICES is a not-for-profit research institute encompassing a 
community of research, data, clinical experts and a secure and accessible array of 
Ontario's health-related data. The Institute for Clinical Evaluative Sciences is able to 
anonymously link population-based health information at an individual patient level, 
using unique ICES identifiers that ensure the privacy and confidentiality of health 
information [43, 44]. For the purposes of this study ICES linked data from the following 
data bases Discharge Abstract Database (DAD), Same Day Surgery (SDS), Registered 
Persons Database (RPDB) and the Ontario Health Insurance Plan (OHIP). These data 
bases allowed the identification of procedure codes, diagnosis codes that were applicable 
to the study populations (see below for identification of study population) for the period 
of study. Diagnostic and procedural information for all hospitalizations and one-day 
procedures are recorded in the Canadian Institute for Health Information’s (CIHI) 
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discharge abstract and same-day surgery databases. Diagnosis codes were obtained from 
the International Classification of Diseases, Ninth (ICD-9: 1979-2005) and Tenth 
Revision (ICD-10: 2001- present). Codes for the surgical procedures were obtained from 
the Canadian Classification of Health Interventions (CCP: 1978-2002) and Canadian 
Classification of Diagnostic, Therapeutic and Surgical Procedures (CCI: 2002- present) 
codes.  Patient characteristics and baseline demographics were obtained from the 
Population and Demographics database (POP).  
 
 
 
1.4.4. Study Population 
 Data was collected for all patients who met the inclusion criteria (Appendix A) 
who underwent one of the 2 index procedures TEF or pyeloplasty in the 4 tertiary centres 
in Ontario for the last twenty years (1993-2013). Patients were excluded if they did no 
have the diagnosis of the congenital defect and met exclusion criteria (Appendix B). The 
cohort was stratified into four, five years block to observe trends over time: 1993-1997, 
1998-2002, 2003-2007, 2008-2013. These two initial data sets built the primary cohort of 
patients that were then followed to study outcomes related to the surgery (Appendix C 
and D). The 4 centres were very comparable in that all centres performed the identified 
procedures on a regular basis by subspecialty trained paediatric surgeons and provided 
similar support for the pre and post-operative care of the patients.  
 
1.4.5. Outcomes 
 
1.4.5.1. Demographics/ Baseline variables 
 Demographic data and baseline variables (e.g. volume of surgeries per centre/per 
surgeon/ era) associated with each cohort were collected and varied according to each 
procedure. For example in the TEF cohort data was collected around age at time of 
procedure, length of hospital stay, sex rurality etc. 
 
1.4.5.2. Primary Outcome 
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 Primary outcomes were established for the 2 index procedures and reflected a 
reoperation similar to the primary procedure. For example in the case of pyeloplasty the 
primary outcome was redo pyeloplasty (evidence of a redo pyeloplasty within 2 years of 
the index event). 
 
1.4.5.3. Secondary Outcomes 
 Secondary outcomes were chosen specifically to represent complications other 
than the primary outcome. For example in pyeloplasty the need for a ureteric stent 
insertion after the index procedure might reflect leakage or obstruction from the 
anastomosis of ureter to the pelvis of the kidney. 
1.4.6. Analysis 
 Data were reported for the complete 20 year period, stratified by year and by 
centre.  The centres are described as A, B, C or D for the purpose of anonymity. Privacy 
regulations do not allow the presentation of any groups with data points <6. Where 
possible, data were analyzed using standard summary statistics ANOVA for continuous 
variables, Kruskal-Wallis test and Chi square test (categorical variables). P value <0.05 
was considered to represent a significant difference between data sets.   
 
1.5. Data Presentation 
 The data presented in this thesis is described in a series of chapters. The data are 
complete for the procedures TEF and pyeloplasty.  
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2.1. Background 
 
 Esophageal Atresia (EA) is a congenital condition in which there is a disruption in 
the continuity of the esophagus (Fig. 1). Esophageal atresia can occur in isolation or with 
a connection, known as a fistula to the trachea (tracheoesophageal fistula (TEF: Fig. 1).  
 
 
Figure 1. The Gross classification of esophageal atresia. 
 
 
 The anomaly results from an insult occurring within the fourth week of gestation, 
during which time separation of the trachea and esophagus usually occurs by folding of 
the primitive foregut [1,2]. Most cases occur sporadically without evidence of either 
hereditary or specific environmental teratogenic causes [3,4,5]. The incidence of EA/TEF 
varies between 2.55 and 2.82 per 10,000 births [3,4,5]. Esophageal atresia and TEF 
present in many forms and it should be thought of as a spectrum of anomalies. There are 
five main anatomic variants: EA with distal TEF (85%), pure EA (7%) known as a long 
gap, EA with proximal TEF (1%), EA with proximal and distal TEF (1%) and H-type 
fistula without EA (4%). The most frequently used classification was proposed by Gross 
in 1953 (Fig.1) [6]. 
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 The early disturbance in organogenesis causing EA/TEF may affect the 
organogenesis of other organs or systems developing at the same time. The most frequent 
associated malformations encountered with EA are: Cardiac (13%-34%), Vertebral (6%-
21%), Limb (5%-19%), Anorectal (10%-16%) and Renal (5%-14%) [4, 5, 7]. The 
constellation of these anomalies is known as the VACTERL association (V= vertebral 
anomalies, A=anorectal malformations, C=Cardiovascular anomalies, 
T=tracheoesophageal fistula, E=esophageal atresia, R=renal anomalies or radial 
anomalies and L=limb defects). Mortality among babies with the VACTERL association 
is not insignificant but is not related to the EA/TEF but more to other identified 
prognostic factors such chromosomal abnormalities, major cardiac anomalies, renal 
anomalies, weight less than 1500g and gestational age <28 weeks. [8-13]. Thus although 
coincident anomalies may affect 40-60% of patients, it seems that EA/TEF is not a 
significant factor for these patients’ mortality [14-16]. 
 Surgical correction of TEF has been performed since 1941 [17] via a postero-
lateral thoracotomy using an extra-pleural approach in most cases. Since 1943 when the 
first report was published the procedure itself has essentially remained unchanged [18] 
until Bax and van der Zee  in 2002 reported their experience using thoracoscopy for EA 
and TEF repair [19,20].  
 The pitfalls of the operation, the incidence of complications and the outcomes, 
both short term and long term, have been reported by many paediatric surgeons around 
the world.  However it is important to note that most of the studies are retrospective 
single centre chart reviews [14, 21-26]. Complications specifically related to the surgical 
procedure include early esophageal anastomotic leak, stricture and recurrence of TEF.  
Anastomotic leaks are reported to occur in 8-16% of cases and most of them are treated 
conservatively [27-30]. Esophageal strictures are very common 4-80% [23, 24, 27, 30-
33] and most of them respond to dilatations [33, 34]. Recurrent TEF occurs in 3-14% of 
patients after the initial operation [15, 23-28, 35].  Patients who have undergone a TEF 
repair will often have associated dysphagia 20-40% [32, 36-38], gastroesophageal reflux 
(GERD) (27–85 %) [36, 39-41] or tracheomalachia (16-33%) [23,42-44]. The treatment 
of those conditions are variable, occasionally surgical intervention is required, such as a 
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fundoplication in the face of severe reflux but often conservative non-operative 
measurements are successful [21,23,37-39,42]. 
 
The relationship between volume of surgical procedures and surgical outcome has 
been broadly studied in the adult literature [45]. The results trend towards a positive 
relation between volume and outcomes, but there are also studies that suggest minimal 
effect. There are only few studies in paediatric surgery that have examined the volume 
outcome relationship and most of these are in paediatric cardiac surgery [46]. Of the few 
that have looked at non-cardiac procedures most of them have determined outcomes 
related to mortality only [47, 48] or to the specific training of the surgeon. Results are 
further confounded by the inclusion of data from those procedures carried out in 
children’s hospitals alone and those from combined adult/ children’s centres [49-51]. For 
example a large study by Shawn et al., reported that the outcomes of patients undergoing 
pyloromyotomy for hypertrophic pyloric stenosis were better in patients who were treated 
by a specialty trained paediatric surgeon compared to a general surgeon [12,49].  
The purpose of this study was first to determine the number of TEF repairs in Ontario 
over the last 20 years and second to evaluate the association of centre volume/surgeon 
volume with post-operative complications in children undergoing TEF repair, utilizing 
data from well-established province-wide healthcare databases held at the Institute for 
Clinical Evaluative Sciences (ICES) 
  
2.2. Patients and Methods    
2.2.1. Study Design  
 A population based retrospective cohort study of all paediatric patients 
undergoing TEF repair at 4 paediatric centres in Ontario (Hospital for Sick Children in 
Toronto (HSC), Children’s Hospital of Eastern Ontario in Ottawa (CHEO), McMaster 
Children’s Hospital in Hamilton, Children’s Hospital of Western Ontario in London) 
between April 1st 1993 and March 31st 2013 was carried out. The province of Ontario, 
Canada has universal access to hospital care and these encounters are recorded in large 
population-based health care databases dating back to 1988. Administrative datasets were 
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linked using unique, encoded identifies and analyzed at the Institute for Clinical 
Evaluative Sciences (ICES).  
2.2.2. Data Sources 
 Diagnostic and procedural information for all hospitalizations and one day 
procedures were obtained from the Canadian Institute for Health Information’s (CIHI) 
discharge abstract (DAD), same day surgery (SDS) databases and Ontario Health 
Insurance Plan (OHIP). Patient characteristics and baseline demographics were obtained 
from the Registered Persons Database (RPDB). Data Cases were identified using codes 
of TEF from International Classification of Diseases, Ninth and Tenth Revision (ICD-9 
until 2002 and ICD-10 since April 1, 2002 for discharge diagnoses (up to 16 fields) and 
procedure codes for TEF surgical repair procedures using the Canadian Classification of 
Health Interventions (CCP) until 2002 and Canadian Classification of Diagnostic, 
Therapeutic and Surgical Procedures (CCI) 2002 onwards.  These databases hold 
approximately 53350 codes that describe procedure and diagnosis codes. Specific codes 
were used to identify the initial cohort and then the primary and secondary outcomes 
associated with TEF repair. The number of specialty trained paediatric surgeons at each 
Institution for the period of study was obtain by personal communication (Dr. S. Jones) 
 
2.2.3. Cohort Build 
 
 All patients undergoing a primary TEF repair (index procedure) between April 1st 
1993 and March 31st 2013 at the following 4 paediatric centres in Ontario, Canada were 
identified. Data were abstracted from the time of the index procedure until two years of 
follow up or until death. All paediatric patients resident in Ontario aged 180 days or 
younger who were Ontario residents when the index (initial TEF repair) procedure was 
performed were included in the study. Patients were excluded if they were not registered 
in ICES, older than 180 days, not residents of Ontario, died before the index procedure, 
that were not operated on in the one 4 paediatric teaching centres (see paragraph 2.2.1.) 
and patients who had the procedure done because of other, non-congenital diagnosis (e.g. 
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injury or malignancy). Eight hundred and twenty five underwent tracheoesophageal 
fistula repair during the last 20 years in Ontario, after excluding criteria were applied 465 
paediatric patients remained in the cohort (Table 1). 
 
Step Number excluded 
Number 
included 
Original cohort Before Exclusion 825 
Missing sex or age 9 816 
Death prior to index date 0 816 
Age >= 180 days 322 suppressed 
Non-Ontario resident NR (included in step below) suppressed 
No diagnosis of TEF 60 days 
prior to index da 
NR (included in step below) suppressed 
Procedure not performed at 
pediatric teaching 
 
NR (included in step below) suppressed 
Evidence of other esophageal 
injury 
 
29 465 
 
Table 1. TEF cohort build. 825 patients underwent  TEF repair; after excluding adult patients and that 
who had this procedure done, but not associated with the diagnosis of  congenital TEF,  465 newborns who 
had TEF repair in Ontario in the last 20 years remained in the cohort.  
 The cohort was stratified into four, five years block to observe trends over time: 
1993-1997, 1998-2002, 2003-2007, 2008-2013. We analyzed outcomes up to two years 
after the index surgery.  Patients were excluded if sex or date of birth were missing, if 
death occurred prior to the index event, or if there was no diagnosis of TEF associated 
with the hospital discharge date within 60-days prior to the index procedure (including 
the procedure date) in DAD or SDS. Patients were also excluded if the encounter was 
associated with evidence of other esophageal injury or malignancy within 60-days before 
the index date (including the index date) in DAD or SDS. 
2.2.4. Outcome 
 
 The primary outcome was reoperation of TEF repair and or surgery for definitive 
reconstruction of the esophagus (gastric pull-up or intestinal pull-up). Secondary 
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outcomes were identified as: other surgical procedures of the bronchus, trachea and 
esophagus, insertion of a gastrostomy tube, the procedure of dilatation of esophageal 
stricture, assessment of esophageal patency /motility/GERD by radiological contrast 
study (upper gastrointestinal study (UGI)) and “other” surgical interventions that 
occurred related to the TEF repair.  
 
2.2.5. Analysis 
 
 Data is reported for the complete 20 year period, stratified by year and by centre.  
The centres are described by the A, B, C or D for the purpose of anonymity. Privacy 
regulations do not allow the presentation of any groups with data points <6, these are 
indicated by NR in tables. Where possible, data were analyzed using standard summary 
statistics ANOVA for continuous variables, Kruskal-Wallis test and Chi square test 
(categorical variables). P value <0.05 was considered to represent a significant difference 
between data sets.   
2.3. Results 
2.3.1. Patient and Centre Characteristics 
 A total of 465 patients from the 4 centres met the criteria for inclusion in the 
primary cohort (both diagnosis of TEF and procedures of TEF repair: Table 1).  
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Code 
 
Description of code 
 
Frequency 
 
1GJ86ME 
 
Closure of fistula, trachea open approach for 
fistula terminating at esophagus [e.g. 
tracheoesophageal fistula] with simple apposition 
for closure [e.g. suture] 
 
48 
1GJ86MEXXE 
 
Closure of fistula, trachea open approach for 
fistula terminating at esophagus [e.g. 
tracheoesophageal fistula] using local flap [e.g. 
strap muscle] 
 
9 
1NA84QE Construction or reconstruction, esophagus with 
tracheoesophageal fistula repair Open thoracic 
approach 
 
178 
1NA84QJ Construction or reconstruction, esophagus with 
tracheoesophageal fistula repair Open thoraco-
abdominal approach 
 
12 
4363 
 
Closure of other fistula of the trachea 202 
5441 
 
Esophagoesophagostomy 16 
Table 1A. Distribution of patients undergoing primary tracheoesophageal fistula repair 
identified by the procedure codes (CCP and CCI). 
As expected all primary procedures were completed as an inpatient. Of the primary 
cohort 41.5% of patients were females and 58.5% were males. The mean age of the index 
surgery was 7.7 days (SD 21.49) and there was no significant difference in age of 
primary operation between institutions (Table 2).  
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 All Age of patients undergoing  TEF repair (index procedure) by 
institution 
 
A B C D  
Mean SD Mean SD Mean SD Mean SD Mean SD p-value 
(from 
ANOVA) 
Patient 
age 
(days) 
7.7 21.49 6.64 24.41 5.18 12.14 8.78 21.47 7.44 24.77 0.05 
 
 
Table 2.  Age distribution of patients at time of index tracheoesophageal repair (TEF) 
repair (index procedure) between institutions shown for the institutions A, B, C and D. 
 
The average number of primary TEF repairs was 23.25/year for the last 20 years (Fig. 2).   
 
 
Figure 2. Number of tracheoesophageal fistula (TEF) repairs in Ontario over the last 20 
years (1993-2012). 
The number of TEF repairs for the eras: 1993-97, 1998-2002, 2003-2007 and 2008-2013 
was 126, 122, 113 and 104 respectively (Fig. 3).  
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Figure 3. Mean number of tracheoesophageal fistula repairs (TEF) per institution A,B,C 
and D stratified by 4 time periods. To ensure anonymity of primary and secondary outcomes it is 
important to note that the identification assignment of the institutions in is this figure is not carried through 
the remainder of the manuscript. 
There is statistically significant difference in patient volume per institution (Table 3) for 
the 20 years of study.  
 
 
 All Number of TEF procedures per institution per year  
A B C D  
Mean SD Mean SD Mean SD Mean SD Mean SD p-value 
(from 
ANOVA) 
Patient 
annual 
volume 
5.8 4.41 3.95 2.01 3.65 1.42 3.35 2.85 12.3 2.74 <0.05 
 
 
Table 3.  Mean annual volume of primary tracheoesophageal fistula repairs (index 
procedure) per institution. To ensure anonymity of primary and secondary outcomes it is important to 
note that the identification assignment of the institutions in is this table is not carried through the remainder 
of the manuscript. 
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The maximum number of primary TEF repairs per surgeon was 2.5/year and this has 
fallen with time to numbers that range from <1 to 1.5 cases per surgeon (Fig. 4).  
 
 
 
 
Figure 4. The average number of tracheoesophageal fistula repairs (TEF) repairs per 
surgeon at institutions A, B, C and D stratified by era. To ensure anonymity of primary and 
secondary outcomes it is important to note that the identification assignment of the institutions in is this 
figure is not carried through the remainder of the manuscript. 
 
 
2.3.2. Outcomes 
2.3.2.1. Primary Outcomes 
 Five percent (n=25/465) of the primary cohort went on to require reoperation, 16 
of them for recurrent fistula and 8 with intestinal interposition. Due to the very low 
numbers of patients undergoing a gastric pull up the site of the reoperations or pull up 
procedures cannot be identified (Table 4). 
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 All Primary Outcomes at institutions  
A B C D  
No. % % % % % p-value 
Primary 
Outcome 
(Total) 
25 5.3  
 
 
not reportable 
not 
reportable 
TEF repair 16 3.4 not 
reportable 
Gastric 
pull-up 
not reportable not 
reportable 
Intestinal 
pull-up 
8 1.7 not 
reportable 
 
Table 4. The primary outcome of patients undergoing tracheoesophageal fistula (TEF) 
repair.  Patients can contribute to more than one outcome component but can only occur 
once in the total number (composite number).   
2.3.2.2. Secondary Outcomes 
 A gastrostomy tube was performed on 144 (31%) of TEF patients and ranged 
from 15-38% between institutions (Table 5).  
 
 All Secondary outcomes at institutions  
A B C D  
N= % % % % % p-value 
Gastrostomy 
tube 
144 31 27.4 28.4 37.8 15.2 <0.05 
Esophageal 
dilatation 
212 45.6 53.4 50.7 41.9 45.6 >=00.5 
Upper GI 
study  
126 27.1 27.4 31.3 22.8 36.7 >=00.5 
Fundoplication 51 11 Not reportable not 
reportable 
 
Table 5. Number of secondary outcomes in patients having undergone a 
tracheoesophageal fistula repair by institution. 
 
Dilatation for oesophageal stricture was reported in 45.6% of TEF patients (range 41.9-
53.4% between institutions). An upper GI study was performed in (27.1% patients and 
ranged between 22.8-36.7% between institutions (Table 5). As expected the number of 
surgical procedures of the bronchus after primary TEF repair was very low (n=6) for the 
20 years of study (Table 5A). 
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Other  Surgical Interventions 
 
All Outcomes at institutions  
A B C D  
Number of 
events 
%  % % % % p-value (from Chi-
square test) 
Total number of interventions 206 44.3 53.4 52.2 41.1 39.2  >= 0.05 
Bronchus intervention 6 1.3 not reportable not reportable 
Mediastinal intervention 41 8.8 not reportable not reportable 
Tracheal intervention 92 19.8 21.9 23.9 17.5 21.5  >= 0.05 
Esophageal intervention 105 22.6 16.4 34.3 24 13.9 < 0.05 
Thoracic duct intervention 
not 
reportable 
not 
reportable 
not reportable not reportable 
Table 5A.  Other Surgical Interventions. Different than reoperation, but related to bronchi, 
mediastinum, trachea, esophagus and thoracic duct. 
19,8% of patients underwent 92 procedures that were identified under the general 
classification of tracheal procedures. These were most commonly minor thoracic 
interventions associated with pleural drainage e.g. drainage, pleura using percutaneous 
catheter (intercostal) with underwater seal drainage system or drainage, pleura using open 
approach and leaving drainage tube in situ, that occurred after the index procedure date 
(Table 5B). 
Tracheal Interventions n=92 Esophageal Interventions n=105 
Code Description Frequency Code Description Frequency 
1GV52LATS Drainage pleura using 
open approach and 
leaving drainage tube 
in situ 
29 5475 Repair of esophageal 
stricture 
44 
1GV52HAHE Drainage pleura using 
percutaneous catheter 
with underwater seal 
drainage system 
24 5479 Other Repair of 
Esophagus 
15 
4396 Other operations on 
trachea 
9 1NA80DBXXE Repair, esophagus 
using local 
transposition flap, 
using endoscopic 
abdominal approach 
8 
   1NA80LBXXE Repair, esophagus 
using local 
transposition flap, 
using  open abdominal 
approach 
8 
   5474 Repair of other 
esophageal fistula 
6 
Table 5B. Tracheal and Esophageal Interventions codes. 
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There were many other codes that were identified to involve the trachea, but the numbers 
were too small to report on an individual basis (Table 6). 
 
 
Code Description No. 
1GJ86DAW3 Closure of fistula, trachea endoscopic approach for 
fistula terminating at esophagus [e.g. 
tracheoesophageal] with simple 
<=5 
1GV52HATK Drainage, pleura using percutaneous catheter with 
suction pump, (under water seal or negative pressure) 
<=5 
1GJ54JATS Management of internal device, trachea of tube (e.g. T-
tube, drainage tube) 
<=5 
1GV52DATS Drainage, pleura using endoscopic approach and leaving 
drainage tube in situ 
<=5 
1GJ50BANR Dilation, trachea endoscopic approach using stent <=5 
1GJ80DA Repair, trachea with simple apposition[e.g. suture] 
endoscopic (percutaneous) approach 
<=5 
 
Table 6. Examples of “Tracheal repair” codes that were used in such small number (<6) 
and therefore could not be reported. 
 
 
 There was no significant difference in the percentage of tracheal procedures between 
institutions (range 17.5-23.9%: p>0.05% from Chi-square test). A total of 22.6 % (range 
13.9-34.3%: Fig. 5) of patients underwent an esophageal procedure. There was a 
statistical difference between institutions in other oesophageal repair (range 17.5-23.9%: 
p<0.05% from Chi-square test). 
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Figure 5.  Percentage of other esophageal repairs at institutions A, B C, and D. 
 
 The majority of these interventions were related to repair of esophagus/esophageal 
stricture (n=105). It is difficult to interpret this data, it is likely that number of stricture 
repairs is overestimated as there was no CCP code that described an esophageal 
dilatation, just esophageal stricture repair. It is likely that during the first 10 years of the 
study the code for stricture repair was used to describe an esophageal dilatation.  The 
remaining procedures were associated with codes that occurred in very small numbers, 
and were also related to repair of esophagus by flap etc. (Table 7).  
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Code Description No. 
1NA80LB 
Repair, esophagus using apposition technique [e.g. suturing] 
for closure using open abdominal approach [includes: 
cervical with abdominal approach, transhiatal approach] 
<=5 
1NA76QD 
Bypass, esophagus thoracic approach [may include cervical 
with thoracic approach] Esophagoesophagostomy 
<=5 
1NA80BA 
Repair, esophagus using apposition technique [e.g. suturing] 
for closure using endoscopic per orifice approach 
<=5 
1NA80QB 
Repair, esophagus using apposition technique [e.g. suturing] 
for closure using open thoracic approach [includes: open 
cervicothoracic approach] 
<=5 
546 Esophagomyotomy <=5 
1NA77SQ 
Bypass with exteriorization, esophagus using chest wall 
[subcutaneous] tunnel exteriorization technique 
<=5 
 
 
Table 7. Examples of “Esophageal repair” codes that were identified but that could not be 
reported due to small numbers. 
 
Fundoplication for GERD was performed on 51 (11%) patients and the numbers are too 
small to report institutional distribution (Table 5). Insertion of a gastrostomy tube was 
performed in 31% of the total cohort of patients following TEF repair. There was a 
significant difference in insertion rate between institutions ranging from 15.2% to 37.7% 
(p<0.05). 
 
 
2.4. Discussion 
 
 This is the first study of its kind, with the exception of paediatric cardiac surgery, 
that a complex paediatric surgical procedure has been used to investigate the relationship 
not only between surgical hospital volume and outcome but also describes the number of 
cases per surgeon. Tracheoesophageal fistula repair was chosen since it is a procedure 
that is associated with a surgical technique that really has not changed over the last 20 
years, the period of data collection. Over the last 10 years there has been a shift towards 
the minimally invasive approach towards TEF repair but this has yet to be adopted widely 
within the province of Ontario and only over the last 5 years. Tracheoesophageal fistula 
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repair does occur with other congenital anomalies but the technical aspects of the 
outcomes of the repair itself for the most part are not affected by those anomalies. This 
study chose not to look at factors such as mortality and hospital stay which would be 
likely to be influenced by other factors than just the post-operative course related to TEF 
repair, especially if the patient had other significant co-morbidities such as complex heart 
disease. Rather outcomes were chosen that were specific to the repair of TEF, were 
accurately described in the data sets that were used and were commonly found in patients 
who had undergone TEF repair. We acknowledge we may have lost some patients in our 
primary outcome group as they may have died before going to redo TEF, but this number 
would likely be very small as the overall mortality inpatitnts undergoing TEF repair is 
very low [16,27]. 
 
 The result of this study demonstrate that even in the province of Ontario with a 
birth rate of approximately 140,000 per year and with a data collection of 20 years it is 
still difficult to generate data on an index procedure with such a low occurrence as TEF. 
The results of this study suggest that the incidence of TEF in Ontario is consistent with 
previously published data [12, 27, 35, 52, 53] and that it decreased over the study period.  
This may be a result of antenatal diagnosis and termination of pregnancy in fetuses with 
other severe congenital anomalies in association with TEF.  
 
 Interestingly as the incidence of TEF has decreased the number of paediatric 
surgeons performing the repair has increased over time. In 1993 there were 13 
subspecialty trained paediatric surgeons working in the 4 hospitals and this increased to 
20 in 2013 (Dr. S. Jones personal communication). The data clearly shows that one centre 
in Ontario provides care to 50% of the patients in the province undergoing the primary 
TEF repair, with the remaining 50% being split approximately evenly between the other 3 
centres. In contrast, when one considers individual surgeon volume the differences 
become minimal especially during the last era studied, 2008-20012, the volumes per 
surgeon are about 1 TEF repair per year. This is a very low volume and assumes there is 
no one particular surgeon that specializes in TEF repair at each centre. To the authors 
knowledge there is no such specialization in the centres studied. In fact in smaller, non-
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teaching centers, is common practice to ensure that two surgeons are present for TEF 
repairs (Dr. S. Jones personal communication).  Due to limitations in billing practise 
during the period of the study it would be impossible to accurately determine the number 
of surgeons attending a case. Of the 4 centres in Ontario, 3 have residency training 
programs, it is assumed, that all residents would attend TEF repairs and as such would 
have significantly greater exposure to cases per year than the individual primary surgeon. 
Although we have the approximate number of surgeons per era per institutions we do not 
have data on the specifics of each surgeon, for example how long they had been in 
practise and whether they worked pull or part time. 
 
 The primary outcome, recurrent TEF repair occurred in 3.4% of the primary 
cohort. This rate is at the lower end of values reported in the literature. The numbers 
reported for each centre were less than 6, suggesting that all centres contribute to the 
reoccurrence rate. We presume that the incidence of reoperation is very similar in all 
institutions as all pediatric surgeons in Ontario have very similar if not the same training 
and most of them use similar care pathways. 
One of the complications associated with TEF repair is anastomotic leak.  There is no 
coding that can be used to identify those cases but the placement of a pleural drainage 
device after the day of the index procedure might represent the non-operative, preferred, 
management of an esophageal leak. This occurred in approximately 10% of patients and 
is similar to rates reported in the literature.  The rate of esophageal dilation was very 
consistent with reports in previous literature and very similar between institutions [52-
54].  
 
 This study demonstrated that over 20 years in Ontario the complication rate 
associated with TEF repair is comparable with reported rates, if not lower. It also 
demonstrates that with the exception of repair/resection of stricture of esophagus stricture 
and insertion of gastrostomy tube all other outcomes are comparable between centres. It 
is beyond the limits of this study to identify the particular centre and the specifics of the 
esophageal procedures carried out in that centre. However these findings highlight the 
need for a future study when with a specific request the data can be further examined to 
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look at this complication. This analysis may then highlight differences in clinical 
practices such as of segmental resection of the esophagus versus continued dilatation or a 
different technique of dilatation.  
 Although this study is the first of its kind, to use population based data sets to 
look at TEF outcomes it has identified a number of limitations. Unfortunately the 
numbers of the index procedure are low and as was demonstrated when primary and 
secondary outcomes are also infrequent occurrences, the specifics of the outcomes in 
relation to site cannot be determined. In this study it may be of minimal significance as 
the rate of most of the outcomes was very low suggesting the overall success of the 
procedure is excellent. This study did not attempt to validate the codes used to identify 
the secondary outcomes and this would be an important step, for example, when 
investigating the centre specific difference in esophageal repair. These are limitations that 
are likely to apply to a significant number of the complex paediatric procedures and this 
highlights the difficulty in determining volume outcome relationships in the surgical 
paediatric population. Due to coding limitations this study was unable to address the 
influence that thoracoscopic TEF may have had on the primary and secondary outcomes. 
 
 In summary this study demonstrated that individual surgeons in Ontario perform 
approximately the same number of TEF repairs each year. The numbers of recurrent TEF 
repairs are very low and a therefore a volume outcome relationship cannot be determined. 
However this is actually reassuring, if the rate of recurrent TEF repair was high then a 
volume relationship could have been observed. The finding that there are differences in 
secondary outcomes will require further investigation.  
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3.1. Background 
 
 Ureteropelvic junction (UPJ) obstruction is a restriction in the flow of urine from 
the renal pelvis to the ureter. The physiologic compensatory response to ureteropelvic 
junction obstruction (UPJO) is the development of renal pelvic hypertrophy and 
hydronephrosis [1-3]. If left uncorrected, it may lead to changes in the renal pelvis, 
pressure-induced injury and consequently irreversible renal damage. The cause of 
obstruction is a narrowed segment of the proximal ureter at the UPJ and lack of 
peristalsis at the site of narrowing. The narrowing can be due to interruption of the 
circular musculature of the UPJ, valvular mucosal folds or lower pole crossing vessel [4-
6]. Ureteropelvic junction obstruction coexists with severe vesicoureteral reflux (VUR) in 
about 10% of cases [7].   
 There are other congenital malformations, which are commonly associated with 
UPJO. Up to 10-50% of affected children may have other urologic abnormalities such as 
UPJO of the contralateral kidney, renal dysplasia and multicystic kidneys or unilateral 
renal agenesis [8, 9]. Bilateral UPJO is reported commonly in the literature (10-40%)  
and is most commonly associated with fetal or neonatal hydronephrosis [10, 11]. In many 
of these cases, the hydronephrosis normalizes after birth and UPJO requiring operative 
intervention is rare [13-15]. 
 Various surgical procedures have been described for the treatment of UPJO in 
children, such as endopyelotomy or dismembered pyeloplasty - the excision of the 
affected proximal ureter fragment and then re-anastomosis. Pyeloplasty can be performed 
as an open procedure (OP) [16, 17], laparoscopically (LP) [18], or as a retroperitoneal 
[19] or transperitoneal [20] robot-assisted laparoscopic procedure [21, 22]. The 
dismembered Anderson-Hynes pyeloplasty has remained the gold standard for the 
treatment of UPJO since it was first described in the late 1940s, with success rates of 
more than 90% [23].  
 There are a few factors that have been reported to influence the surgical outcomes 
of pyeloplasty. Braga et al., 2010 [24] reported an increased reoperation rate amongst 
patients who were operated on by dorsal lumbotomy vs. lumbar approach (8.3 vs. 2.3%) 
and who did not have retrograde pyelography (RPG) (8.3 vs. 2.1 reoperation rate) [24, 
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25]. In many studies open pyeloplasty (OP) and laparoscopic pyeloplasty (LP) have 
shown comparable outcomes in terms of complications, but there are reports of 
differences in other variables such as length of stay [26-29]. Mei et al., in 2011 reviewed 
1403 studies and found a decreased length of stay in patients undergoing a LP versus OP 
and no difference between the two procedures in terms of complication rate [26]. In 2015 
Huang et al., again reported a shorter LOS but prolonged operative time and reduced 
complication rates in LP vs. OP. Another factor that influences the complications 
associated with pyeloplasty is the use of trans anastomotic stents during the operation. 
Some studies have shown that outcomes are not related to stent insertion during the 
procedure [28-30], while other reports show an advantage of using the stent (less 
incidence of leakage or cloth obstruction and shorter LOS) [27].  
 
 Paediatric pyeloplasty is a highly successful procedure. Success rates in excess of 
90-98% are uniformly reported, regardless of the technique used to perform the 
procedure (open surgery, trans and retroperitoneal laparoscopy, or robotic-assisted) [16, 
24, 31, 32]. Nevertheless, a 3%-10% failure rate has been consistently described in 
published reports [25, 33, 34] and the ideal approach to this small subset of patients with 
a failed pyeloplasty is yet to be determined.  
 
 The relationship between the volume of surgical procedures and surgical 
outcomes has been broadly studied in adult literature [35, 36]. Overall the results trend 
towards a positive relationship between volume and outcomes. There are few studies in 
paediatric surgery, especially in paediatric urology, that have examined this volume-
outcome relationship. Currently most of the studies in the literature are from paediatric 
cardiac surgery [37] and most have determined outcomes related only to mortality [38, 
39] or to the specific training of the surgeon [40, 41]. Results are often confounded by the 
combination of data from operations carried out at children’s hospitals and combined 
adult/paediatric centres [40, 42, 43]. In paediatric urology there are few studies, which 
report outcomes of urological procedures performed by paediatric urologists. Wang et al., 
2015, compared outcomes in paediatric urology (ureteral re-implant, 
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ureteroureterostomy, pyeloplasty, radical nephrectomy, partial nephrectomy, bladder 
extrophy repair, appendicovesicostomy, bladder augmentation, vesicostomy, bladder 
neck sling and percutaneous nephrolithotomy) and found a positive relation between 
hospital volume and outcomes [44]. Unfortunately this study included various types of 
hospitals: metropolitan teaching and nonteaching, and nonmetropolitan, and 75% of these 
hospitals performed less than 5 major paediatric urology operations annually. The study 
reported a higher volume of complications such as acute renal failure, urinary tract 
infection, postoperative respiratory complications, systemic sepsis, postoperative 
bleeding and in hospital death in the low volume centres [44]. Two other studies that 
looked at outcomes following ureteral reimplantation demonstrated a positive volume-
outcome relationship with regards to surgeon volume but not hospital volume [45, 46]. 
Later, Nguyen et al., similarly demonstrated a positive volume-outcome relationship 
between surgeon volume and outcomes following ureteroneocystostomy [45]. In 2014 
Sturm et al., demonstrated a positive, although minimal, influence of surgeon volume on 
outcomes [47]. One study demonstrated the positive influence of high hospital volume on 
pyeloplasty outcomes, although it demonstrated worse outcomes if the procedure was 
performed laparoscopically versus open in both high and low volume centres [48]. 
 There are a few surgical complications that can occur following pyeloplasty: 
urinary tract or wound infection, postoperative bleeding (rare), postoperative leakage at 
the anastomotic site and recurrence of obstruction [16, 24, 25, 31-34, 49]. Most infections 
can be easily managed by antibiotics. Leakage can be treated by the insertion of a double 
J stent (DJ) or insertion of a nephrostomy tube. Success of the pyeloplasty is defined as 
improvement in hydronephrosis and stabilization or improvement in renal function. 
 Recurrence of obstruction is considered a late complication which requires 
surgical intervention ranging from minimally invasive endourologic procedures, such as 
stent insertion and endopyelotomy, to more extensive and challenging operations such as 
redo pyeloplasty and ureterocalicostomy [50]. A Canadian study by Braga et al., [51] 
reported a success rate of 39% with endopyelotomy compared to 100% following a redo 
pyeloplasty. Asensio et al., 2015 reported comparable outcomes, all be it in a small 
number of patients undergoing an open redo pyeloplasty versus a robotic assisted 
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pyeloplasty [33]. The result of laparoscopic redo pyeloplasties are also excellent 
(Abraham et al., 2015) [52]. A Canadian study by Romao et al., 2013, [50] showed a 
pyeloplasty failure rate of 5.9% in patients undergoing either an OP or LP. The failures 
were managed with success by DJ stent insertion (6%), endopyelotomy (50%), redo 
pyeloplasty (92%), and ureterocalicostomy (100%).  
 Most of above studies reported outcomes from single centres [16, 19, 21, 24, 25, 
32, 51] or combined data from both adult and paediatric centres, and different urological 
procedures [17, 20, 26, 30, 31]. This makes it difficult to determine the effect on 
outcomes related specifically to either hospital or surgeon volume or specific procedure 
[44-48]. A study should be carried out that looks at outcomes between similar centres that 
provide the same operation on paediatric patients. The purpose of this study was to first 
determine the volume of pyeloplasties being carried out in Ontario and second to evaluate 
the association of centre volume and surgeon volume on post-operative complications in 
children undergoing pyeloplasty repair, utilizing data from well-established province-
wide healthcare databases held at the Institute for Clinical Evaluative Sciences (ICES) 
 
3.2. Patients and methods    
 
3.2.1. Study Design  
 
 A population based retrospective cohort study of all paediatric patients 
undergoing pyeloplasty repair at 4 paediatric centres in Ontario (Hospital for Sick 
Children in Toronto (HSC), Children’s Hospital of Eastern Ontario in Ottawa (CHEO), 
McMaster Children’s Hospital in Hamilton, Children’s Hospital of Western Ontario in 
London) between April 1st 1993 and March 31st 2013 was carried out. The province of 
Ontario, Canada has universal access to hospital care and these encounters are recorded 
in large population-based health care databases dating back to 1988. Administrative 
datasets were linked using unique, encoded identifiers and analyzed at the Institute for 
Clinical Evaluative Sciences (ICES).  
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3.2.2. Data Sources 
 Diagnostic and procedural information, length of stay and readmission to the 
hospital (within 21 days after the index procedure) for all hospitalizations and one day 
procedures were obtained from the Canadian Institute for Health Information’s (CIHI) 
discharge abstract (DAD), same day surgery (SDS) databases. Patient characteristics and 
baseline demographics were obtained from the Registered Persons Database (RPDB). 
Cases were identified using discharge diagnosis codes (up to 16 fields) for  UPJO from 
the International Classification of Diseases, Ninth and Tenth Revision (ICD-9 prior to 
2002 and ICD-10  April 1, 2002- present) and procedure codes for pyeloplasty 
procedures using the Canadian Classification of Health Interventions (CCP: prior to 
2002) and the Canadian Classification of Diagnostic, Therapeutic and Surgical 
Procedures (CCI: 2002 to present). Data was obtained via personal communication 
regarding the number of specialty trained paediatric surgeons at each institution for the 
period of the study (Dr. S. Dave) 
 
3.2.3. Cohort Build 
 
 All patients undergoing a primary pyeloplasty (index procedure) between April 
1st 1993 and March 31st 2013 at the 4 paediatric centres in Ontario, Canada were 
identified. Data was abstracted from the time of the index procedure (pyeloplasty) until 
two years of follow up or until death. All paediatric patients resident in Ontario aged 18 
years or younger, who were Ontario residents when the index (initial pyeloplasty) 
procedure was performed, were included in the study. Patients were excluded if they 
were not registered in ICES, if sex or date of birth were missing, older than 18 years or 
were non- residents of Ontario. Further exclusions included death of the patient before 
the index procedure, those who were not operated on in the one 4 paediatric teaching 
centres (see paragraph 6.2.1.), if there was no diagnosis of UPJO upon hospital discharge 
date within 360-days prior to the index procedure (including the procedure date) in DAD 
or SDS. The cohort was stratified into four, five years block to observe trends over time: 
1993-1997, 1998-2002, 2003-2007, 2008-2013. 
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3.2.4. Outcomes 
 The primary outcome was reoperation for UPJO. Secondary outcomes were 
defined as procedures other than reoperation that resulted in either the need for temporary 
or definitive release of a secondary obstruction; they included bypass/ureterocalicostomy, 
insertion of DJ stent, delayed stent removal, pyelotomy/dilatation, nephrostomy 
tube/external drainage and nephrectomy. Length of stay (LOS) and readmission rates 
were also determined.  
 
3.2.5. Analysis 
 
 Data is reported for the complete 20 year period, stratified by year and by centre.  
The centres are described by the A, B, C or D for the purpose of anonymity. The 
identification assignment for each institution is not consistent between tables and figures. 
Privacy regulations do not allow the presentation of any groups with data points <6, these 
are indicated by NR in tables. Where possible, data were analyzed using standard 
summary statistics ANOVA for continuous variables, Kruskal-Wallis test and Chi square 
test (categorical variables). P value <0.05 was considered to represent a significant 
difference between data sets.   
 
3.3. Results 
 
3.3.1. Patient and Centre Characteristics 
 
 A total of 1714 patients from the 4 centres met the criteria for inclusion in the 
primary cohort (both diagnosis of UPJO and procedures indicating pyeloplasty repair 
(Table 8). 
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Inclusion criteria 
Code Description of code Frequency 
6777 CORRECTION OF 
URETEROPELVIC JUNCTION 
784 
1PE80PF Repair, renal pelvis open posterior 
[flank] approach Using apposition 
technique (e.g. suturing 
248 
1PE80PFXXE Repair, renal pelvis open posterior 
[flank] approach Using local flap 
189 
1PE80DA Repair, renal pelvis endoscopic 
(percutaneous) approach Using 
apposition technique [e.g. suturing] 
171 
1PE80LA Repair, renal pelvis open approach 
[posterior] Using apposition 
technique [e.g. suturing] 
141 
1PE80DAXXE Repair, renal pelvis endoscopic 
(percutaneous) approach Using local 
flap [e.g. Y V, spatulated spiral, 
vertical, advancing) 
124 
1PE80LAXXE Repair, renal pelvis open approach 
[posterior] Using local flap [e.g. Y V, 
spatulated spiral, vertical, advancing) 
44 
 
Table 8. Distribution of patients undergoing primary pyeloplasty (index procedure) 
identified by the procedure codes (CCP and CCI) 
 
As expected most primary procedures (>90%) were completed as an inpatient. Of the 
primary cohort 28.9% of patients were females and 71.1% were males. The mean age of 
the index surgery was 60.9 months (SD 62.7) and mean 80.7, 71.0, 57.0, 56.9 months 
respectively in institutions A, B, C and D. There was a significant difference in age of 
primary operation between institutions (Table 9). 
 
 All Age of  patients undergoing pyeloplasty (index procedure) by institution   
A B C D  
Mean SD Mean SD Mean SD Mean SD Mean SD p-value 
(from 
ANOVA) 
Patient 
age 
(months) 
60.9 62.7 80.7 
 
72.1 71 62.6 57.0 60.7 56.9 61.1 <0.05 
 
Table 9. Age distribution of patients at time of index pyeloplasty shown for the 
institutions A, B, C and D. 
The average number of primary pyeloplasty repairs was 85.7/year for the last 20 years 
(Fig. 6).   
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Figure 6. Number of pyeloplasties performed in Ontario over the last 20 years (1993-
2013) 
The number of pyeloplasties for the eras: 1993-97, 1998-2002, 2003-2007 and 2008-2013 
was 432, 432, 443 and 407 respectively. Annual frequency per institution A, B, C and D 
is presented in Figure 7.  
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Figure 7. Mean number of pyeloplasties per institutions A, B, C and D, stratified by 4 
year time periods. To ensure anonymity of primary and secondary outcomes it is important to note that 
the identification assignment of the institutions in is this figure is not carried through the remainder of the 
manuscript. 
 
There is statistically significant difference in patient volume per institution for the 20 
years of study (Table 10). 
 
 All Number of pyeloplasty procedures (Primary exposure) by 
institution 
 
A B C D  
Mean SD Mean SD Mean SD Mean SD Mean SD p-value 
(from 
ANOVA) 
Patient 
annual 
volume 
21.43 16.94 19.2 
 
4.42 8.15 3.27 10.25 4.01 48.1 8.66 <0.05 
 
Table 10.  Mean annual volume of pyeloplasty (index procedure) procedures per 
institution. To ensure anonymity of primary and secondary outcomes it is important to note that the 
identification assignment of the institutions in is this table is not carried through the remainder of the 
manuscript. 
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The maximum mean number of primary pyeloplasty repairs per surgeon was 21/year and 
this has fallen with time to numbers that range from a mean of 4 to 11 cases per surgeon 
per era (2008-2012: Fig. 8).  
 
 
 Figure 8. The average number of pyeloplasty repairs per surgeon at institutions A, B, C 
and D stratified by era. To ensure anonymity of primary and secondary outcomes it is important to 
note that the identification assignment of the institutions in is this figure is not carried through the 
remainder of the manuscript. 
 
3.4. Outcomes 
 
3.4.1. Primary Outcomes 
 
 Following pyeloplasty, 91.1% of patients did not require any other surgical 
intervention. Four percent (n=68/1714) of the primary cohort went on to require 
reoperation (primary outcome) and there was no statistical difference in this reoperation 
rate between institutions (range 3.4-4.9%: p0.05% from Chi-square test: Table 11).  
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3.4.2. Secondary Outcomes 
 
Secondary outcomes were identified as those surgical interventions other than 
reoperation. After primary pyeloplasty, 71 patients (4.1%) had an endoscopic procedure 
either endopyelotomy or dilatation. The number of pyelotomies/dilatations performed at 
the different institutions ranged from 1.6-5.2% (p<0.05% Chi-square test: Table 11). 
Fifty four patients (3.2%) required percutaneous drainage or nephrostomy and there was 
a statistical difference between institutions (range 1.6-7.3%: p<0.05% Chi-square test: 
Table 11). The number of patients who underwent an ureterocalicostomy is too small to 
report. Twenty one patients (1.2%) who did not have a stent inserted during the index 
procedure required a stent insertion within the first 10 weeks after the index procedure. 
There were 121 patients (7.1%) who had an endoscopy performed more than 10 weeks 
after the index procedure, which may represent late stent insertion, reinsertion if they 
were removed, or late stent removal related to prolonged leakage (Table 11). Twelve 
patients (0.7%) eventually went on to nephrectomy and the numbers are too small to 
report per institution.  
 
Overall 124 patients (7.2%) were re-admitted to hospital within first 21 days after 
the operation, and there was a statistical difference between institutions (range 3.7-
27.3%: p<0.05%: Chi-square test). Overall post-operation LOS was 4.92 days-mean (SD-
5.14) and there was statistical difference between institutions (mean range 4.26-7.52%: 
p<0.05%:  ANOVA).  
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Events (secondary 
outcomes) 
All Outcomes at institutions  
A B C D  
Number 
of events 
% of 
patients, 
in which 
the event 
appeared  
% % % % p-value (from 
Chi-square 
test) 
Patients who had any 
surgical intervention after 
pyeloplasty 
153 8.9 11 11.7 6.5 8.9 0.05 
Reoperation 68 4 4.9 3.4 3.9 4 0.05 
Pyelotomy/dilatation 71 4.1 4.3 3.9 1.6 5.2 <0.05 
Nephrectomy 12 0.7 not reportable not reportable 
External 
drainage/nephrostomy 
54 3.2 3.1 7.3 1.6 2.9 <0.05 
Bypass/Ureterocalicostomy not reportable not reportable not reportable 
Stent insertion <=70 days 21 1.2 not reportable not reportable 
Stent insertion/removal >70 
days 
121 7.1 not reportable not reportable 
Readmission within 21 days 124 7.2 3.7 27.3 3.9 4.9 <0.05 
 
Table 11. Number patients who underwent a surgical intervention following pyeloplasty 
by institution.  
 
 
The ability to identify an open versus a laparoscopic pyeloplasty was not possible 
before 2002. In the period 2003-2007 23.3 percent of all pyeloplasties were performed 
laparoscopically and this increased to 44.2% during 2008-2012 (Table. 12).  
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Number (Percentage) of pyeloplasties by era 
 No.of 
Pyeloplast
ies since 
2002 
% of all 
Pyeloplasties 
since 2002 
1993-1997 1998-2002 2003-2007 2008-2012 p-value 
from Chi-
square test 
Open 
Pyeloplasty  
634 37 N/A N/A 76.7 55.8 <0.05 
Laparoscopic 
Pyeloplasty 
296 17.3 N/A N/A 23.3 44.2 
 
Table 12. Number (percentage) of pyeloplasties undertaken open or laparoscopically 
reported by era since 2002. 
 
 
There was no statistical difference in the number of laparoscopic pyeloplasties 
between institutions (range 11.2-19.5%: p<0.05%: Chi-square test) during the last 20 
years (Table. 13). During the time periods 2003-2007 and 2008-2012 when the incidence 
of laparoscopic pyeloplasties was increasing, the success rate was (91.0 vs. 90.9%) and 
the reoperation rate (3.8 vs. 4.2%: Table 14). 
 
 
 
Number (percent) of laparoscopic pyeloplasties performed in the institutions A, B, C, D for the 
20 year study period 
Missing 
(pre-2002) 
All 
institutio
ns 
Number 
All 
institutio
ns % 
A (%) B (%) C (%) D (%) p-value from 
Chi-square 
test 
Open 
Pyeloplasty 
634 37 32.5 34.1 39.6 37.3 >0.05 
Laparoscopi
c 
Pyeloplasty 
296 17.3 17.2 11.2 14.8 19.5 
 
Table 13. Total number (percent) of laparoscopic pyeloplasties carried out at the 
individual institutions during the study period. 
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There was no statistical difference in the reoperation rate between the four eras (range 
3.2-4.6%: p>0.05%: Chi-square test). Dilatation/ pyelotomy, nephrectomy, stent insertion 
within 70 days and bypass/ ureterocalicostomy rates were very low and not reportable. 
There was a statistical difference between eras in the number of nephrostomies that were 
carried out. Nephrostomy rates decreased with time from 6.5% in 1993-1997 to 1.5% in 
2008-2012 (range 1.5-6.5%: p<0.05%: Chi-square test).  There was a statistically 
significant decrease in readmission rates between eras from 12% in 1993-1997 compared 
to 5.2% in 2008-2012 (Table 14).  
 
 
 All Outcomes divided by era  
1993-
1997 
1998-
2002 
2003-
2007 
2008-
2012 
 
No. % % % % % p-value (from 
Chi-square 
test) 
Primary Outcome 153 8.9 10.9 6.7 9 9.1 0.05 
Reoperation 68 4 4.6 3.2 3.8 4.2 0.05 
Pyelotomy/dilatation 71 4.1 not reportable not reportable 
Nephrectomy 12 0.7 not reportable not reportable 
External 
drainage/nephrostomy 
54 3.2 6.5 2.3 2.3 1.5 <0.05 
Bypass/Ureterocalicostomy not reportable not reportable not reportable 
Stent insertion <=70 days 21 1.2 not reportable not reportable 
Stent insertion/removal >70 
days 
121 7.1 not reportable not reportable 
Readmission within 21 days 124 7.2 12 8.1 3.6 5.2 <0.05 
 
Table 14. Primary and secondary outcomes following pyeloplasty by era (averages 
(percent) are reported as a combination of all centres). 
 
3.5. Discussion 
 This study was performed to determine the volume and outcomes associated with 
pyeloplasty in the paediatric population in Ontario. This study demonstrated that the 
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overall outcome following pyeloplasty is excellent and has remained stable over the last 
20 years. Although there is a statistical difference in the number of pyeloplasties 
performed between institutions (Table 10), the total number/frequency of these 
procedures has also remained stable over the study period. The reoperation rate remained 
at approximately 4% for the 20 years of the study, this is very comparable to previously 
reported studies [24-30, 51], suggesting that the coding associated with rate of 
pyeloplasty and redo pyeloplasty is accurate.  
Pyeloplasty was chosen as the procedure to investigate the relationship between 
volume and outcome in paediatric urology, as it is an operation where the principles of 
the surgery have not changed over the past two decades, the timeframe when this data 
was collected. The reoperation rate was chosen as the primary outcome rather than 
mortality because mortality is very rare after this procedure and can also be influenced by 
other factors besides the post-operative course. The incidence of pyeloplasty remains 
almost unchanged over the time frame of the study and this also suggests that it is an 
excellent procedure to study. The number of paediatric urologists performing the 
procedure has not undergone a significant change since 1993. At the start of the study 
period there were 8 paediatric urologists in Ontario and at the end of the 2013 there were 
9. The data shows that one centre in Ontario provides care to 50% of patients in the 
province undergoing pyeloplasty, with the remaining 50% of surgeries are split between 
the 3 other centres. In 2014 Sukuma et al., [48] reported better outcomes following 
pyeloplasties that were carried out in centres with high volume than the low volume. 
Hospitals performing 35 open pyeloplasties and/ or and 41 laparoscopic pyeloplasties 
were considered high volume and hospitals performing 16 open pyeloplasties and/or 13 
laparoscopic pyeloplasties were considered low volume. They analyzed 6006 patients and 
looked at intraoperative and postoperative complications, prolonged length of stay, and 
excessive hospital charges. As per Sukuma, one of the centres in our study would fulfill 
the criteria for a high volume centre and the other three would fulfill criteria as low 
volume centres. However the study by Sukuma did not investigate the volume-outcome 
relationship per surgeon. In our study, the volume of patients per surgeon has decreased 
from a mean range of 5-21 patients/ surgeon in the era 1998-2002 to a mean of 4-11 
patients/surgeon in 2008-2012 (Fig. 8). Given that the number of redo pyeloplasties is 
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similar across institutions the data suggests that individual surgeon volume does not 
affect the primary outcome and those surgeons that perform a mean of 4 or more 
pyeloplasties per year are experiencing excellent operative success. It is beyond the scope 
of this study to consider the impact of surgeon experience on the proficiency of the 
individual surgeon and subsequent patient outcomes but it must be taken into 
consideration when interpreting results of this nature. 
 Ninety one percent of patients did not require any surgical intervention following 
pyeloplasty and 4% required a reoperation. These numbers are very comparable with 
previous studies. However this is the first study to compare only academic, tertiary 
paediatric urology centres where patients are only seen by specialty trained urologists 
with specialized trained staff and paediatric specific resources. Most of the previous 
studies have combined data from paediatric and adult centres [47, 48]. Due to very low 
event rates the difference in the number of secondary outcomes per institution is not 
reportable for nephrectomies, bypass/ureterocalicostomies and for stent insertion within 
70 days or stent insertion/removal after 70 days. This in itself reflects the excellent 
outcomes across the province and within the different institutions. There was significant 
differences between institutions in the secondary outcome pyelotomy/dilatations, 
however the number of actual procedures was small (71) relative to the number of 
patients who underwent a pyeloplasty (1714) and the range of numbers between 
institutions was also small  (1.6–5.2%: Table 11). It is therefore difficult to determine the 
clinical significance of this finding, but it would certainly suggest that further 
investigation should be undertaken to determine factors that might identify those patients 
that would be at risk of stricture following pyeloplasty for UPJ obstruction. There was a 
significant difference between institutions in numbers of patients undergoing 
nephrostomy and those requiring readmission within 21 days of the index procedure early 
in the study period however, nephrostomy and readmission rates then dropped over time 
(Table 14).  This suggests a practice change over time that has migrated towards a 
common treatment approach between all of the institutions. 
 It was the original intention of the study to compare volumes and outcomes in 
patients who underwent pyeloplasty and a stent insertion at the time of the primary 
procedure with those without stent insertion. However, the code which differentiates 
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patients who had stent insertion versus those who had no stent inserted at the time of the 
index procedure is not reliably used. Surgeons may report a stent insertion as a separate 
procedure at the time of the index operation and on the other hand may consider it part of 
the index procedure and not record it at all. We found up to 11% of operations reported 
stent insertion during the index procedure by using a CCI/CCP code that was separate 
from the operation code (ureteric stent insertion definition 1). We analyzed the incidence 
of stent removal after the index procedure, without any stent insertion between the index 
day and removal day (ureteric stent insertion definition 2). This would correspond with 
stent insertion that was most likely performed during the surgery, but was not coded for 
at the time of surgery. We found that when the index procedure and both stenting 
definitions were combined, the percentage of stented pyeloplasties reached 47.8% for all 
20 years and 65.8% for pyeloplasties performed between 2008-2012. Sturm et al., 2014 
reported a urinary diversion rate of 45% during OP and 83% during laparoscopic 
procedures [47]. In the one of the biggest Canadian studies in 2008, Braga et al., reported 
a stent rate of 87% during the pyeloplasty procedure [25]. Although our results are 
somewhat comparable with the literature stent rates must be interpreted with extreme 
caution. The need to use a combination of definitions to identify stent insertion at the 
time of surgery demonstrates that the coding at the time of the index procedure is very 
inaccurate- if there is a stent removal code but never an insertion code. Furthermore the 
assumption that a stent removal without a code for a stent insertion is an accurate proxy 
to calculate the number of stent insertions is also flawed, again it relies on the assumption 
that insertion did not occur after the index procedure. An additional issue is that stents, 
which do not require surgical removal or which fall out spontaneously are not captured if 
the stent insertion is not recorded at the time of the primary procedure. A further 
limitation of the study is the inability to identify the site of operation (right versus left 
versus bilateral) using CCI/CCP codes. It is very rare to undertake bilateral pyeloplasty 
and most authors agree that pyeloplasty should be performed on one side first followed 
by an operation on the contralateral side 1-2 month later [53-57]. The reoperation rate in 
our study was reported 6 months after the index procedure and although possible 
contralateral pyeloplasty be captured as a “reoperation” in that period it is unlikely since 
most contralateral index events would occur within the 6 month time frame.  
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 This study demonstrated that over 20 years in Ontario the complication rates 
associated with pyeloplasty are comparable with rates reported by other studies.  It also 
demonstrates that with the exception of dilatation/pyelotomy, nephrostomy and 
readmission within 21 days, all other outcomes are comparable between centres. 
Moreover, the incident of nephrostomies and readmission rate are decreasing over time. It 
is beyond the limits of this study, due to privacy issues, to identify particular centres, 
nevertheless given differences in dilatation/ pyelotomy between centres further 
investigation will be required.  This may occur in the form of permission to specifically 
identify centres and then address clinical pathways, surgical technique etc. It may also 
take the form of a working group with representation from each centre where open 
discussion and standards of care can be generated. 
In summary this study highlights the difficulties of using data abstraction and the 
quality of the data in the databases themselves. Furthermore it emphasizes the limitations 
of reporting small numbers of outcomes. These problems are not specific to paediatric 
urology but are applicable to any surgery that has small index volumes. It certainly raises 
the need to improve data abstraction, coding and the ability to collect data across Canada 
in multi centred studies to determine outcomes, especially as it relates to complex 
paediatric surgical procedures.  
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4.0. General Discussion and Conclusions 
As outlined in the introductory chapter the outcome of many surgical procedures have 
been shown to be linked to a number of factors including the clinical condition of the 
patient, the perioperative care, the complexity of the surgical procedure and the 
experience of the surgeon. Over the past few decades, many studies, across a variety of 
surgical procedures have shown that the outcomes of certain surgical procedures are 
related to the volume of operations performed at that center. Patients treated in hospitals 
performing more operations are more likely to have fewer complications [1,2]. 
 
Pediatric surgery volume outcome studies are difficult to undertake because we have a 
limited number of patients and certain procedures are rarely performed. Comparing the 
outcomes between centers is thus difficult, but comparing single surgeon experience in 
particular centers may be even more challenging. We compared patient related outcomes 
at the 4 academic paediatric centres in Ontario, which are similar in structure, staff 
availability, resources and organization. It was anticipated that a province with such a 
large population would provide volumes of surgical procedures that would allow us 
to study a volume/outcome relationship. 
 
We planned to compare 2 complex paediatric surgical procedures, which are only 
performed in paediatric tertiary centers by specialized paediatric surgeons. The technique 
of the procedures chosen for the study was well known and relatively common, was 
treated the same way in different centers and has not changed throughout the time. We 
have chosen procedures, on which comorbidities have minimal impact on outcomes, 
however it is acknowledged that it is impossible to choose procedures of which treatment 
outcome is completely independent from other comorbidities. Pyeloplasty is an example 
of operation, which comorbidities, if even exist, are likely not related to the outcome of 
the procedure. Although patients with TEF may have comorbidities and sometimes they 
can be quite serious, like cardiac defects, the actual complications of TEF repair are 
likely related to other congenital problems.  
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The purpose of this study was to determine the volume of two complex pediatric surgical 
procedures at tertiary centers in Ontario over the last 20 years. We studied the outcomes 
and explored the possible relationship between outcomes and volume. The study 
incorporated the use of ICES data sets to determine the volume and outcomes of the 
complex surgical procedures tracheoesophageal fistula (TEF) repair and pyeloplasty.  
 
In brief a population based retrospective cohort study of all pediatric patients undergoing 
TEF repair and pyeloplasty at tertiary pediatric centers in Ontario was carried out. In 
Ontario each patient encounter is recorded in large population-based health care data 
bases dating back to 1988. These datasets were linked using unique, encoded identifies 
and analyzed at the ICES. Specific codes for congenital disease like TEF and UPJO were 
chosen from ICD-9 and ICD-10 codes and the cohort of patients with those defects were 
assigned. Repair procedures codes for those congenital diseases were chosen from CCI 
and CCP codes lists. The index procedure of pyeloplasty and TEF repair were 
identified as described in detail in chapters 2 and 3. The primary outcome was 
identified and was the same for both procedures – reoperation, which was similar to 
the index procedure.  As reoperations, we also included procedures, which are 
equivalent to reoperation like gastric pull up-equivalent of re-do TEF repair or 
calicoureterostomy-equivalent of re-do pyeloplasty. Secondary outcomes were 
chosen based on clinical experience and review of the literature and were reflection 
of possible clinical pathway after these kinds of operations. They were different for 
different operations and take into account the complexity of the procedures. 
Secondary outcomes of TEF repair were: other surgical intervention on bronchus, 
trachea and esophagus and procedures related to esophageal obstruction like: insertion of 
a gastrostomy tube, dilatations of esophageal stricture or radiological contrast study 
related to dysmotility. Secondary outcomes of pyeloplasty, although different than in 
TEF, are the same in nature: related to obstruction in UOJ segment: dilatations, 
catheterization drainage or nephrostomy. 
 
The data was presented for all institutions and for individual centers but the centres were 
de- identified as A,B,C or D. The labelling of centres was also not consistent to prevent 
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association of results with outcomes of specific centres. The cohorts were stratified into 
four five years block to observe trends over time: 1993-1997, 1998-2002, 2003-2007, 
2008-2012. We analyzed the date in these block periods in an attempt to maximise the 
number of patients per data point. All the patients with diagnosis codes and repair codes 
were included into the main cohort.    
 
Four hundred and sixty five patients met the criteria for inclusion in the primary cohort of 
TEF repair. This is a very small number to look at volume outcome relationships if the 
volume is then broken down further into numbers per institution and era and the 
occurrence rate of the outcome is low. Reporting of outcomes then becomes limited by 
the privacy regulations that prevent the presentation of groups that contain less than 6 
data points in any of the reporting cells within that specific analysis. In contrast, 1714 
patients met the criteria for inclusion in the primary cohort of patients having undergone 
pyeloplasty. This cohort is four times bigger than the TEF cohort and the numbers are 
comparable to that of another recently published Canadian study [3]. The average number 
of primary TEF repairs was 23.25/year for the last 20 years and although one institution 
carried out one third of the TEF repairs with the remainder being split between the other 
3 centers, the actual volume per surgeon was very similar. Similarly the average number 
of primary pyeloplasties was 85.7/year for the last 20 years with one of the institution 
performing approximately 50% of the case. Although data is reported by individual 
surgeon it may not reflect the expertise around the operating table at the time of 
procedure. For example in some of the smaller centers 2 surgeons will often attend index 
cases. Also in resident training programs a chief resident may have had exposure to 
anywhere between 4-15 TEF repairs per year and the same period the attending surgeon 
may  have only undertaken 1 repair. Such information cannot be obtained from the data 
bases used in this study and would require review of the operative record from each 
individual chart.   
 
Both TEF repair and pyeloplasty reoperation rates (5.3% and 4% respectively) are low 
and similar to that reported in the literature [3, 4]. There was no statistical difference 
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between institutions in the rate of reoperation following index pyeloplasty and 
unfortunately due to the limitations as described above such as low volumes, primary 
outcome event rates and the limitation of reported only cell numbers greater than 6 
statistic could not be presented for TEF. These findings highlight that in order to 
determine if a volume outcome relationship exists for recurrent TEF the paediatric 
surgical community to across Canada would have to combine data and potentially stratify 
outcomes into low versus high outcome centres. This low vs. high volume centers 
comparison would be especially beneficial when we would recruit more centers from 
other provinces and we would be able to compare at least few high volume centers and 
several lower volume institutions. 
 However this data does suggest that that the rate of recurrent fistula and the need for 
reoperation in Canada is low. The Canadian pediatric surgical community is very small 
and this in its self provides a number of checks and balances. Most of the pediatric 
surgeons currently working in Ontario were trained in the province or in Canada. It is 
likely that a centre with very high complication rates would quickly be identified.  
 Secondary outcomes following TEF repair reflect not only the outcome of the surgery, 
but also reflect clinical care pathways and are likely more heavily influenced by patient 
comorbidities. For example the rate of gastrostomy tube insertion was significantly 
different between institutions (range 15.2 -37.7%). Children with TEF have often 
problems with poor esophageal motility and dysphagia, resulting in poor nutritional status 
of the patient. Some surgeons prefer conservative treatment and nutritional 
supplementation via a nasogastric tube while others proceed promptly to gastrostomy 
tube insertion. It certainly would be interesting to look more closely at those centres with 
a higher gastrostomy insertion rate and determine patient co-morbidities, the reason for 
gastrostomy tube insertion and who for example was making the decision for gastrostomy 
tube insertion, a gastroenterologist, complex feeding team or a surgeon. Otherwise, we 
would like to underline that gastrostomy is not a pure complication. It is reassuring that 
the rate of postoperative esophageal dilatation following TEF repair was similar between 
institutions, since this likely reflects the success of the surgical technique. An esophageal 
stricture is very common in patients following TEF repair with reported rates varying 
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from 4 to 80% in the literature [4, 5], very similar to those found in our study. There was 
a statistical difference between institutions in the category of other oesophageal repair 
(range 17.5-23.9%). It is difficult to interpret this data, it is likely that number of stricture 
repairs is overestimated as there was no CCP code that described an esophageal 
dilatation, just esophageal stricture repair. It is likely that during the first 10 years of the 
study the code for stricture repair was used to describe an esophageal dilatation. 
Furthermore, this group of procedures includes over 85 codes. Most of them are related to 
repair of the esophagus likely following dilatation of a stricture, as described above or 
they were used to describe treatment of a leak or resection of the esophagus for a 
recalcitrant stricture. It may also be related to a different approach to esophageal 
strictures such as a preference for limited esophageal resection rather than dilatation. This 
certainly raises the need to look more closely at this outcome either at an institutional 
level or more regionally at the approach to esophageal stricture.  
This also highlights the fact that accurate data relies upon the accurate coding of the 
procedure. Many of codes and not précised or unambiguous and as we presented, there is 
only one code representing TEF repair or Pyeloplasty. Also the codes need additional 
interpretation as they may be used in similar, but not the same procedures and it reflects 
the code construction: very wide definitions of procedures (from older CCP codes list) 
and detail oriented, but also not only one code, which represent actually the same 
operation (recent, CCI codes). 
 
Secondary outcomes following pyeloplasty were variable between institutions. For 
example there was a significant difference in the number of pyelotomy/dilatations and 
percutaneous drainage procedures following pyeloplasty. However in reality the number 
of these interventions is small and consequently it is difficult to determine the clinical 
significance in terms of assessing the success of the initial pyeloplasty. The difference in 
the rate of nephrostomy tube insertion and readmission rate following the index 
procedure suggests a practice change over time as both have decreased in the last eras of 
the study. The incidence of stent insertion after the index procedure is significantly 
different between institutions; this may be related to surgeon preference for stent 
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insertion at the time of index procedure. If the surgeon did not originally place a stent and 
a leak occurs they then have to place a stent- a situation that could be avoided if the stent 
was placed at the original operation.  Although many paediatric urologists place a stent 
during the index procedure, they do not code it separately. Thus is it difficult to 
determine accurately what proportion of patients a stent had inserted at the index 
procedure. This is an example of the many issues that are encountered when using data 
which relies on accurate coding by the data abstracters, the availability of appropriate 
codes to assign to the procedure and the accuracy of the operative/nursing notes, 
discharge summaries from which the data abstracter obtains the appropriate codes.  This 
limitation has to be considered for all data in this study.  
In conclusion we have demonstrated that, although the data for our study was collected 
from the entire province over the last 20 years, it is still a small paediatric cohort. Our 
study showed that the recurrence rate of TEF and UPJO in Ontario is very small, which 
demonstrates overall very good outcomes. The volume of patients was so small that we 
were unable to demonstrate volume and outcome relationships. This study highlights the 
difficulties of data abstraction and the quality of the data in the databases themselves. It 
emphasizes the limitations of reporting outcomes from small numbers associated with the 
paediatric environment. The differences in secondary outcomes will require further 
investigation, which may occur in the form of permission to specifically identify centers 
and then address clinical pathways, surgical technique etc. This study also raises the need 
to improve data abstraction, coding and the ability to collect data across Canada in multi-
centered studies to determine outcomes, especially as it relates to complex paediatric 
surgical procedures. 
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5.0. Appendices 
 
Appendix A.  
 
Example of the inclusion criteria used in the cohort build. (Tracheoesophageal Fistula 
(TEF), Pyeloplasty, Ventriculo-peritoneal shunt (V-P shunt)) 
 
 
TEF repair Pyeloplasty V-P shunt insertion 
Patients who have unique ICES identifiers in the database. We included patients in fiscal 
years 1993 to 2013 (fiscal year runs from April 1st to March 31st of the following year). 
Patients who were Ontario residents at the time of index procedure. 
Patients who had index procedure performed at a paediatric teaching centre in Ontario 
including following cities: London, Ottawa, Hamilton, or Toronto. 
Age<180 days Age<18 years Age<18 years 
ICD-9 and ICD-10 codes for 
TEF diagnosis 
ICD-9 and ICD-10 codes for 
congenital UPJ obstruction 
ICD-9 and ICD-10 codes for 
hydrocephalus 
CCP and CCI coded for 
TEF repair 
CCP and CCI coded for 
Pyeloplasty 
CCP and CCI coded for V-P 
shunt insertion 
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Appendix B.  
 
Example of the exclusion criteria used in the cohort build 
(Tracheoesophageal Fistula (TEF): Pyeloplasty, Ventriculo-peritoneal shunt (V-P shunt)) 
 
 
 
 
TEF repair Pyeloplasty V-P shunt insertion 
Patients not registered in ICES  
Patients who were not Ontario residents at the time of index procedure. 
Patients who had index procedure performed at a different centre than Ontario ( including 
following cities: London, Ottawa, Hamilton, or Toronto) 
Age>180 days Age>18 years Age>18 years 
ICD-9 and ICD-10 codes 
different than for TEF 
diagnosis (exclusion list) 
ICD-9 and ICD-10 codes 
different than for congenital 
UPJ obstruction 
ICD-9 and ICD-10 codes 
different than for 
hydrocephalus 
CCP and CCI coded for 
different than TEF repair 
CCP and CCI coded 
different than for 
Pyeloplasty 
CCP and CCI coded 
different than for V-P shunt 
insertion 
Patients who died prior to the index procedure 
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Appendix C.   
Example of procedure (CCP and CCI) and diagnosis codes (ICD 9 and 10) that were used 
to identify the primary cohort. These represent codes that were used to create the primary 
cohort for tracheoesophageal fistula repair (Chapter 2.). 
Procedure code Procedure description 
1NA84QE 
Construction or reconstruction, esophagus with tracheoesophageal 
fistula repair Open thoracic approach 
1NA84QJ 
Construction or reconstruction, esophagus with tracheoesophageal 
fistula repair Open thoraco-abdominal approach 
1GJ86ME 
Closure of fistula, trachea open approach for fistula terminating at 
esophagus [e.g. tracheoesophageal fistula] with simple apposition for 
closure [e.g. suture] 
1GJ86MEW3 
Closure of fistula, trachea open approach for fistula terminating at 
esophagus [e.g. tracheoesophageal] with simple apposition and fibrin 
[glue] 
1GJ86MEXXA 
Closure of fistula, trachea open approach for fistula terminating at 
esophagus [e.g. tracheoesophageal fistula] using autograft 
1GJ86MEXXE 
Closure of fistula, trachea open approach for fistula terminating at 
esophagus [e.g. tracheoesophageal fistula] using local flap [e.g. strap 
muscle] 
Diagnosis Code Diagnosis description 
4363 Closure of other fistula of trachea 
5441 Esophagoesophagstomy (intrathoracic) 
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Appendix D.  
 
Example of Cohort build; TEF repair (Chapter 2) 
 
Build cohort step No of excluded No of included 
Original cohort Before Exclusion 825 
Missing sex or age 9 816 
Death prior to index date 0 816 
Age >= 180 days 322 494 
Non-Ontario resident NR (included in step below) suppressed 
No diagnosis of CEF 60 
days prior to index da 
NR (included in step below) suppressed 
Procedure not performed at 
paediatric teaching 
NR (included in step below) suppressed 
Evidence of other 
esophageal injury 
29 465 
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